These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 7041847
1. [Steroid hormone receptors and their relevance for the therapy of mammary cancers (author's transl)]. Heise E. Arch Geschwulstforsch; 1981; 51(8):727-36. PubMed ID: 7041847 [Abstract] [Full Text] [Related]
2. Steroid receptors in breast cancer. Desombre ER. Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047 [Abstract] [Full Text] [Related]
3. [New data on relations between residual hormonal modulability and medical treatment of breast adenocarcinoma]. Prodi G, Lollini PL, Nicoletti G. Minerva Med; 1984 Feb 18; 75(6):219-21. PubMed ID: 6709205 [No Abstract] [Full Text] [Related]
4. Clinical relevance of steroid hormone receptors. Gürtler R, Görlich M. Arch Geschwulstforsch; 1985 Feb 18; 55(5):387-97. PubMed ID: 4062496 [Abstract] [Full Text] [Related]
5. [Hormone receptors and breast cancer prognosis]. Saez S, Pichon MF. Pathol Biol (Paris); 1983 Dec 18; 31(10):801-8. PubMed ID: 6366701 [Abstract] [Full Text] [Related]
6. Steroid hormone receptors in the management of human breast cancer. Knight WA, Osborne CK, Yochmowitz MG, McGuire WL. Ann Clin Res; 1980 Oct 18; 12(5):202-7. PubMed ID: 7015982 [Abstract] [Full Text] [Related]
7. Relationship of presence of progesterone receptors to prognosis in early breast cancer. Pichon MF, Pallud C, Brunet M, Milgrom E. Cancer Res; 1980 Sep 18; 40(9):3357-60. PubMed ID: 7427948 [Abstract] [Full Text] [Related]
13. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas. Leers MP, Hoop JG, van Beers M, van Rodijnen N, Pannebakker M, Nap M. Cytometry B Clin Cytom; 2005 Mar 18; 64(1):43-52. PubMed ID: 15668953 [Abstract] [Full Text] [Related]
15. [Steroid hormone receptors and endocrine treatment of breast cancer]. Jänne O, Kontula K, Puukka M, Vihko R. Duodecim; 1977 Mar 18; 93(8):509-16. PubMed ID: 872792 [No Abstract] [Full Text] [Related]
16. [Experimental and clinical aspects of hormone therapy in breast cancer (author's transl)]. Maass H, Jonat W. Arch Geschwulstforsch; 1981 Mar 18; 51(7):623-9. PubMed ID: 7337544 [Abstract] [Full Text] [Related]
17. [Studies on the mechanism of the estrogen action in human breast cancer]. Kimura M, Nishimura R, Akagi M. Gan No Rinsho; 1985 Mar 18; 31(3):263-7. PubMed ID: 3999388 [Abstract] [Full Text] [Related]
18. Hormone-receptor assays in breast cancer. A five-year experience. Mercer RJ, Lie TH, Rennie GC, Bennett RC, Morgan FJ. Med J Aust; 1983 Apr 16; 1(8):365-9. PubMed ID: 6835143 [Abstract] [Full Text] [Related]
19. Significance of 1,25-dihydroxyvitamin D3 receptor in primary breast cancers. Eisman JA, Suva LJ, Martin TJ. Cancer Res; 1986 Oct 16; 46(10):5406-8. PubMed ID: 3019526 [Abstract] [Full Text] [Related]
20. [Breast neoplasms: endocrine therapy and importance of steroid hormone receptors]. Maass H, Jonat W. MMW Munch Med Wochenschr; 1979 Nov 02; 121(44):1444-7. PubMed ID: 118334 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]